$0.35
2.86%
Downside
Day's Volatility :14.98%
Upside
12.48%
32.14%
Downside
52 Weeks Volatility :91.89%
Upside
88.05%
Period | Aethlon Medical Inc | Index (Russel 2000) |
---|---|---|
3 Months | -40.66% | 0.0% |
6 Months | -79.55% | 0.0% |
1 Year | -87.12% | 0.0% |
3 Years | -99.06% | -22.3% |
Market Capitalization | 5.3M |
Book Value | $0.63 |
Earnings Per Share (EPS) | -3.85 |
PEG Ratio | 0.0 |
Wall Street Target Price | 3.86 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -50.46% |
Return On Equity TTM | -105.38% |
Revenue TTM | 574.2K |
Revenue Per Share TTM | 0.24 |
Quarterly Revenue Growth YOY | 4278.2% |
Gross Profit TTM | 574.2K |
EBITDA | -10.6M |
Diluted Eps TTM | -3.85 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -5.43 |
EPS Estimate Next Year | -3.51 |
EPS Estimate Current Quarter | -0.31 |
EPS Estimate Next Quarter | -0.2 |
What analysts predicted
Upside of 1002.86%
Sell
Neutral
Buy
Aethlon Medical Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Aethlon Medical Inc | 18.67% | -79.55% | -87.12% | -99.06% | -99.2% |
![]() Stryker Corporation | 12.3% | 0.36% | 24.19% | 28.8% | 65.26% |
![]() Boston Scientific Corp. | 10.6% | 20.32% | 51.42% | 80.93% | 95.5% |
![]() Edwards Lifesciences Corp. | 9.4% | -28.78% | -12.2% | -45.23% | -7.73% |
![]() Abbott Laboratories | 3.57% | -5.84% | 13.1% | -11.32% | 35.19% |
![]() Medtronic Plc | 10.85% | 5.57% | 12.46% | -33.2% | -16.71% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Aethlon Medical Inc | NA | NA | 0.0 | -5.43 | -1.05 | -0.5 | NA | 0.63 |
![]() Stryker Corporation | 39.84 | 39.84 | 2.64 | 12.0 | 0.19 | 0.07 | 0.01 | 51.86 |
![]() Boston Scientific Corp. | 66.34 | 66.34 | 2.01 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
![]() Edwards Lifesciences Corp. | 26.3 | 26.3 | 3.2 | 2.69 | 0.22 | 0.12 | NA | 12.35 |
![]() Abbott Laboratories | 35.92 | 35.92 | 4.16 | 4.66 | 0.14 | 0.06 | 0.02 | 22.6 |
![]() Medtronic Plc | 30.16 | 30.16 | 1.66 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Aethlon Medical Inc | Buy | $5.3M | -99.2% | NA | 0.0% |
![]() Stryker Corporation | Buy | $136.8B | 65.26% | 39.84 | 16.12% |
![]() Boston Scientific Corp. | Buy | $120.2B | 95.5% | 66.34 | 12.0% |
![]() Edwards Lifesciences Corp. | Buy | $40.2B | -7.73% | 26.3 | 23.74% |
![]() Abbott Laboratories | Buy | $198.1B | 35.19% | 35.92 | 13.65% |
![]() Medtronic Plc | Buy | $115.3B | -16.71% | 30.16 | 12.06% |
Insights on Aethlon Medical Inc
In the last 1 year, Boston Scientific Corp. has given 51.4% return, outperforming this stock by 138.5%
In the last 3 years, Boston Scientific Corp. has given 80.9% return, outperforming this stock by 180.0%
TWO SIGMA SECURITIES, LLC
Vanguard Group Inc
Geode Capital Management, LLC
Baader Bank INC
BlackRock Inc
Group One Trading, LP
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Organization | Aethlon Medical Inc |
Employees | 14 |
CEO | Mr. James B. Frakes M.B.A. |
Industry | Health Technology |
A Spac I Acquisition Corp
$0.35
-8.52%
Keyarch Acquisition Corp
$0.35
-8.52%
Connexa Sports Technologies Inc
$0.35
-8.52%
Us Value Etf
$0.35
-8.52%
First Wave Biopharma Inc
$0.35
-8.52%
Global X Msci Next Emerging
$0.35
-8.52%
Fat Projects Acquisition Corp
$0.35
-8.52%
Capital Link Global Fintech
$0.35
-8.52%
Applied Uv Inc
$0.35
-8.52%